Zimmer Biomet Holdings, Inc banner

Wall St Price Targets

ZIM Price Forecast
Based on 24 analysts

+10% Upside
from €86.2 today

Zimmer Biomet Holdings, Inc (ZIM)’s 12-month stock price forecast through October 2027 has a consensus target of €95.18, implying 10% upside. The forecast is based on price targets from 24 Wall Street analysts.

ZIM Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ZIM yet.

Zimmer Biomet Holdings, Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZIM's stock price target?
Price Target
95.18 EUR

According to Wall Street analysts, the average 1-year price target for ZIM is 95.18 EUR with a low forecast of 83.48 EUR and a high forecast of 120.69 EUR.

What is the Revenue forecast for Zimmer Biomet Holdings, Inc?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 7 years is 4%.

What is the Gross Profit forecast for Zimmer Biomet Holdings, Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 7 years is 5%.

What is the Operating Income forecast for Zimmer Biomet Holdings, Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 7 years is 12%.

What is the Pre-Tax Income forecast for Zimmer Biomet Holdings, Inc?
Projected CAGR
38%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 38%.

What is the Net Income forecast for Zimmer Biomet Holdings, Inc?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 7 years is 19%.

Back to Top